Brain-specific protein C activation during carotid artery occlusion in humans.

BACKGROUND AND PURPOSE Activation of plasma protein C (PC) zymogen by thrombin-thrombomodulin at the endothelial surface is an important endogenous antithrombotic mechanism. It is unknown whether activated protein C (APC) is generated in vivo in the cerebrovasculature, because there is only limited thrombomodulin expression in human brain vascular endothelium. Therefore, we tested the hypothesis that carotid occlusion produces brain-specific PC activation. METHODS Blood samples were simultaneously collected from the ipsilateral internal jugular vein and radial artery before and during carotid cross-clamping and on "de-occlusion" in 8 awake patients undergoing routine carotid endarterectomy. Plasma PC zymogen and circulating APC levels were measured using enzyme immunocapture assay and expressed as percent of pooled plasma controls. RESULTS Internal jugular vein APC levels increased 28% exclusively during carotid occlusion and then decreased 32% with de-occlusion (F=8.1, P<0.005). PC zymogen increased only 5.9% with occlusion (F=6.3, P<0.02), consistent with hemoconcentration. There were no changes in radial artery PC or APC levels. CONCLUSIONS These findings demonstrate brain-specific protein C activation in humans during carotid occlusion and suggest a protective role for endogenous APC generation during cerebrovascular occlusion.

[1]  A. Rezaie Rapid activation of protein C by factor Xa and thrombin in the presence of polyanionic compounds. , 1998, Blood.

[2]  S. Schreiber,et al.  Thrombomodulin expression in bovine brain capillaries. Anticoagulant function of the blood-brain barrier, regional differences, and regulatory mechanisms. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[3]  José A Fernández,et al.  Activated protein C correlates inversely with thrombin levels in resting healthy individuals , 1997, American journal of hematology.

[4]  R. Willette,et al.  Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. , 1997, Stroke.

[5]  S. Schreiber,et al.  Regulation of brain capillary endothelial thrombomodulin mRNA expression. , 1996, Stroke.

[6]  José A Fernández,et al.  Impairments of the protein C system and fibrinolysis in infection-associated stroke. , 1996, Stroke.

[7]  J. Jansson,et al.  Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant treatment. , 1996, European heart journal.

[8]  C. Esmon,et al.  The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Hofman,et al.  Reduced Response to Activated Protein C Is Associated with Increased Risk for Cerebrovascular Disease , 1996, Annals of Internal Medicine.

[10]  José A Fernández,et al.  Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation. , 1996, Stroke.

[11]  S. Grey,et al.  A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes. , 1996, Journal of immunology.

[12]  C. Esmon,et al.  Protein C Inhibitor Is a Potent Inhibitor of the Thrombin-Thrombomodulin Complex (*) , 1995, The Journal of Biological Chemistry.

[13]  丸野 元彦 Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains , 1995 .

[14]  S. Grey,et al.  Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. , 1994, Journal of immunology.

[15]  T. Sakamoto,et al.  Prevention of Arterial Reocclusion After Thrombolysis With Activated Protein C: Comparison With Heparin in a Canine Model of Coronary Artery Thrombosis , 1994, Circulation.

[16]  H. Schwarz,et al.  Activation and Inactivation of Human Protein C by Plasmin , 1994, Thrombosis and Haemostasis.

[17]  C. Esmon,et al.  Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. , 1993, The Journal of clinical investigation.

[18]  W. Hacke,et al.  Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke , 1992, Annals of neurology.

[19]  J. Griffin,et al.  Direct detection of activated protein C in blood from human subjects. , 1992, Blood.

[20]  P. Hollaus,et al.  Blood Viscoelasticity Response during Carotid Endarterectomy , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  J. Sadler,et al.  Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. , 1991, The Journal of clinical investigation.

[22]  G. D. Young,et al.  Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits. , 1991, The Journal of laboratory and clinical medicine.

[23]  M. Fisher,et al.  Regional distribution of thrombomodulin in human brain , 1991, Brain Research.

[24]  C. Esmon,et al.  Inflammation and Coagulation: Linked Processes Potentially Regulated Through a Common Pathway Mediated by Protein C , 1991, Thrombosis and Haemostasis.

[25]  C. Esmon,et al.  Protein C Activation Following Coronary Artery Occlusion in the In Situ Porcine Heart , 1991, Circulation.

[26]  J. Griffin,et al.  Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. , 1990, Circulation.

[27]  K. Takatsuki,et al.  Treatment of patients with disseminated intravascular coagulation by protein C , 1990, American journal of hematology.

[28]  K. Mann,et al.  The activation of bovine protein C by factor Xa. , 1989, The Journal of biological chemistry.

[29]  J. Freyssinet,et al.  Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides. , 1989, The Biochemical journal.

[30]  P. Mannucci,et al.  Protein C in acute stroke. , 1988, Stroke.

[31]  A. Chang,et al.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. , 1987, The Journal of clinical investigation.

[32]  C. Bell,et al.  Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain , 1986 .

[33]  C. Esmon Protein-C: biochemistry, physiology, and clinical implications. , 1983, Blood.

[34]  B. Bennett,et al.  Effect of local exercise and vessel occlusion on fibrinolytic activity. , 1977, Journal of clinical pathology.

[35]  A. D. Hall,et al.  Collateral cerebral blood pressure. An index of tolerance to temporary carotid occlusion. , 1973 .

[36]  W. Koroshetz,et al.  Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke. , 1997, The New England journal of medicine.

[37]  J. Griffin,et al.  Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency. , 1993, Blood.

[38]  N. Peyri,et al.  Thrombomodulin in the central nervous system. , 1991, Nouvelle revue francaise d'hematologie.

[39]  C. Bell,et al.  Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain. , 1986, Blood.